Immunic, Inc. (IMUX)
NASDAQ·Healthcare·Biotechnology
$10.55
+5.66%
Mkt Cap $98.49M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | — | — | — | -$0.10 | -$0.12 | -20.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.18 | -$0.13 | +27.78% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.18 | -$0.20 | -11.11% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.25 | -$0.25 | +0.00% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.22 | -$0.25 | -13.64% | — | — |
| Q4 2024 Nov 7, 2024 | $10.00K | — | — | -$0.22 | -$0.24 | -9.09% | — | — |
| Q3 2024 Aug 8, 2024 | $10.00K | — | — | -$0.23 | -$0.21 | +8.70% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.27 | -$0.25 | +7.41% | — | — |
| Q1 2024 Feb 22, 2024 | — | — | — | -$0.51 | -$0.48 | +5.88% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.55 | -$0.51 | +7.27% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.52 | -$0.54 | -3.85% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.54 | -$0.58 | -7.41% | — | — |
| Q1 2023 Feb 23, 2023 | — | — | — | -$0.82 | -$1.63 | -98.78% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.64 | -$0.69 | -7.81% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$0.68 | -$0.72 | -5.88% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$0.80 | -$0.74 | +7.50% | — | — |
| Q1 2022 Feb 24, 2022 | — | — | — | -$0.73 | -$0.81 | -10.96% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$0.81 | -$0.76 | +6.17% | — | — |
| Q3 2021 Aug 6, 2021 | — | — | — | -$0.72 | -$0.82 | -13.89% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.69 | -$1.63 | -136.23% | — | — |